Peer-reviewedCC BYNutrients
GLP-1 Receptor Agonists, Gut Microbiota, and Chronic Pain: Nutritional Signaling at the Gut–Brain Axis
- 1Department of Orthopaedics & Rehabilitation, Yale School of Medicine, New Haven, CT 06510, USA;
- 2Neuromodulation and Digital Health Lab, Yale University, New Haven, CT 06510, USA; (F.R.C.); (I.J.K.)
- 3Department of Anesthesiology, University of Wisconsin–Madison, Madison, WI 53792, USA;
Related
- GLP-1 Receptor Agonists and Risk of Kidney Replacement Therapy and Healthcare Utilization in Bipolar Disorder with Chronic Kidney Disease
- Effectiveness of Adding GLP‐1 Receptor Agonists to SGLT2 Inhibitor Therapy in Chronic Kidney Disease: A Population Based Study
- Comparative Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors on Sepsis in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
- Cognitive behavioral therapy for insomnia–assisted discontinuation or reduction of benzodiazepine receptor agonists and Z-drugs in chronic insomnia: A systematic review and meta-analysis
- Single or multiple nutritional hormone receptor modulators for chronic kidney disease
BibTeX
@article{odonkor2026glp1,
title = {{GLP-1 Receptor Agonists, Gut Microbiota, and Chronic Pain: Nutritional Signaling at the Gut–Brain Axis}},
author = {Charles A. Odonkor and Mustafa R. Dodurgali and Fiona R. Cox and Ian J. Klimov and Alaa Abd-Elsayed},
journal = {Nutrients},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13667044},
note = {CC BY},
}
RIS
TY - JOUR
TI - GLP-1 Receptor Agonists, Gut Microbiota, and Chronic Pain: Nutritional Signaling at the Gut–Brain Axis
AU - Charles A. Odonkor
AU - Mustafa R. Dodurgali
AU - Fiona R. Cox
AU - Ian J. Klimov
AU - Alaa Abd-Elsayed
PY - 2026
DA - 2026/09/22
JO - Nutrients
UR - https://europepmc.org/article/PMC/PMC13667044
SN - 2072-6643
ER -